世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 世界および中国におけるB型肝炎ヒト免疫グロブリン市場の洞察、2027年までの予測Global and China Hepatitis B Human Immunoglobulin Market Insights, Forecast to 2027 市場分析と洞察。世界と中国のB型肝炎ヒト免疫グロブリン市場 当レポートでは、世界および中国のB型肝炎ヒト免疫グロブリン市場に焦点を当てています。 2020年のB型肝炎ヒト免疫グロブリンの世界市場規模はXX百... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー市場分析と洞察。世界と中国のB型肝炎ヒト免疫グロブリン市場当レポートでは、世界および中国のB型肝炎ヒト免疫グロブリン市場に焦点を当てています。 2020年のB型肝炎ヒト免疫グロブリンの世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。中国では、B型肝炎ヒト免疫グロブリンの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。 世界のB型肝炎ヒト免疫グロブリンの範囲と市場規模 B型肝炎ヒト免疫グロブリン市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のB型肝炎ヒト免疫グロブリン市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。 中国市場については、2016-2027年のB型肝炎ヒト免疫グロブリン市場規模をプレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 100IU 200IU 400IU 用途別セグメント 麻疹の予防 B型肝炎ウイルス感染症の予防 A型肝炎ウイルス感染症の予防 その他 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア UAE 会社別 Biotest ADMAバイオロジクス サンクインブラッド バイオプロダクツ研究所 バクスター CSL バイエル Grifols オクタファーマ 花蘭咲 中国バイオロジック 天壇バイオロジック 双林バイオファーマシー（Shuanglin Bio-pharmacy 四川遠大修陽 上海生物学研究所 花蘭 上海RAAS血液製剤 中国大企業 南越生物製薬 博雅生物医薬集団 東路生物医薬 山東泰邦生物医薬股份有限公司 広東双林生物医薬 成都栄勝製薬 深圳偉光生物製薬 緑十字（中国）生物製剤 シノファーム 目次1 Study Coverage1.1 Hepatitis B Human Immunoglobulin Product Introduction 1.2 Market by Type 1.2.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Type 1.2.2 100IU 1.2.3 200IU 1.2.4 400IU 1.3 Market by Application 1.3.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Application 1.3.2 Measles Prevention 1.3.3 Prevention of Hepatitis B Virus Infection 1.3.4 Hepatitis A Virus Infection 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Hepatitis B Human Immunoglobulin Market Size, Estimates and Forecasts 2.1.1 Global Hepatitis B Human Immunoglobulin Revenue 2016-2027 2.1.2 Global Hepatitis B Human Immunoglobulin Sales 2016-2027 2.2 Global Hepatitis B Human Immunoglobulin, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Hepatitis B Human Immunoglobulin Historical Market Size by Region (2016-2021) 2.3.1 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Region (2022-2027) 2.4.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Region (2022-2027) 3 Global Hepatitis B Human Immunoglobulin Competitor Landscape by Players 3.1 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Sales 3.1.1 Global Hepatitis B Human Immunoglobulin Sales by Manufacturer (2016-2021) 3.1.2 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Revenue 3.2.1 Key Hepatitis B Human Immunoglobulin Manufacturers Covered: Ranking by Revenue 3.2.2 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers (2016-2021) 3.2.3 Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Hepatitis B Human Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Hepatitis B Human Immunoglobulin Revenue in 2020 3.2.6 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Hepatitis B Human Immunoglobulin Price by Manufacturers 3.4 Global Hepatitis B Human Immunoglobulin Manufacturing Base Distribution, Product Types 3.4.1 Hepatitis B Human Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hepatitis B Human Immunoglobulin Product Type 3.4.3 Date of International Manufacturers Enter into Hepatitis B Human Immunoglobulin Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Hepatitis B Human Immunoglobulin Market Size by Type (2016-2021) 4.1.1 Global Hepatitis B Human Immunoglobulin Sales by Type (2016-2021) 4.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2016-2021) 4.1.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Hepatitis B Human Immunoglobulin Market Size Forecast by Type (2022-2027) 4.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027) 4.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027) 4.2.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Hepatitis B Human Immunoglobulin Market Size by Application (2016-2021) 5.1.1 Global Hepatitis B Human Immunoglobulin Sales by Application (2016-2021) 5.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2016-2021) 5.1.3 Hepatitis B Human Immunoglobulin Price by Application (2016-2021) 5.2 Hepatitis B Human Immunoglobulin Market Size Forecast by Application (2022-2027) 5.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027) 5.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027) 5.2.3 Global Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 6.1.1 China Hepatitis B Human Immunoglobulin Sales YoY Growth 2016-2027 6.1.2 China Hepatitis B Human Immunoglobulin Revenue YoY Growth 2016-2027 6.1.3 China Hepatitis B Human Immunoglobulin Market Share in Global Market 2016-2027 6.2 China Hepatitis B Human Immunoglobulin Market Size by Players (International and Local Players) 6.2.1 China Top Hepatitis B Human Immunoglobulin Players by Sales (2016-2021) 6.2.2 China Top Hepatitis B Human Immunoglobulin Players by Revenue (2016-2021) 6.3 China Hepatitis B Human Immunoglobulin Historic Market Review by Type (2016-2021) 6.3.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2021) 6.3.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2016-2021) 6.3.3 China Hepatitis B Human Immunoglobulin Price by Type (2016-2021) 6.4 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027) 6.4.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027) 6.4.3 China Hepatitis B Human Immunoglobulin Price Forecast by Type (2022-2027) 6.5 China Hepatitis B Human Immunoglobulin Historic Market Review by Application (2016-2021) 6.5.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2021) 6.5.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2016-2021) 6.5.3 China Hepatitis B Human Immunoglobulin Price by Application (2016-2021) 6.6 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027) 6.6.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027) 6.6.3 China Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027) 7 North America 7.1 North America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 7.2 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 7.2.1 North America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 7.2.2 North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 8.2 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Region 8.2.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2016-2021) 8.2.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 9.2 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 9.2.1 Europe Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 9.2.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 10.2 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 10.2.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 10.2.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 11.2.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 11.2.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Biotest 12.1.1 Biotest Corporation Information 12.1.2 Biotest Description and Business Overview 12.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Biotest Hepatitis B Human Immunoglobulin Products Offered 12.1.5 Biotest Recent Development 12.2 ADMA Biologics 12.2.1 ADMA Biologics Corporation Information 12.2.2 ADMA Biologics Description and Business Overview 12.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Products Offered 12.2.5 ADMA Biologics Recent Development 12.3 Sanquin Blood 12.3.1 Sanquin Blood Corporation Information 12.3.2 Sanquin Blood Description and Business Overview 12.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Products Offered 12.3.5 Sanquin Blood Recent Development 12.4 Bio Products Laboratory 12.4.1 Bio Products Laboratory Corporation Information 12.4.2 Bio Products Laboratory Description and Business Overview 12.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Products Offered 12.4.5 Bio Products Laboratory Recent Development 12.5 Baxter 12.5.1 Baxter Corporation Information 12.5.2 Baxter Description and Business Overview 12.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Baxter Hepatitis B Human Immunoglobulin Products Offered 12.5.5 Baxter Recent Development 12.6 CSL 12.6.1 CSL Corporation Information 12.6.2 CSL Description and Business Overview 12.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.6.4 CSL Hepatitis B Human Immunoglobulin Products Offered 12.6.5 CSL Recent Development 12.7 Bayer 12.7.1 Bayer Corporation Information 12.7.2 Bayer Description and Business Overview 12.7.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Bayer Hepatitis B Human Immunoglobulin Products Offered 12.7.5 Bayer Recent Development 12.8 Grifols 12.8.1 Grifols Corporation Information 12.8.2 Grifols Description and Business Overview 12.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Grifols Hepatitis B Human Immunoglobulin Products Offered 12.8.5 Grifols Recent Development 12.9 Octapharma 12.9.1 Octapharma Corporation Information 12.9.2 Octapharma Description and Business Overview 12.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Octapharma Hepatitis B Human Immunoglobulin Products Offered 12.9.5 Octapharma Recent Development 12.10 Hualan Biological 12.10.1 Hualan Biological Corporation Information 12.10.2 Hualan Biological Description and Business Overview 12.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Products Offered 12.10.5 Hualan Biological Recent Development 12.11 Biotest 12.11.1 Biotest Corporation Information 12.11.2 Biotest Description and Business Overview 12.11.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Biotest Hepatitis B Human Immunoglobulin Products Offered 12.11.5 Biotest Recent Development 12.12 Tiantan Biologic 12.12.1 Tiantan Biologic Corporation Information 12.12.2 Tiantan Biologic Description and Business Overview 12.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Tiantan Biologic Products Offered 12.12.5 Tiantan Biologic Recent Development 12.13 Shuanglin Bio-pharmacy 12.13.1 Shuanglin Bio-pharmacy Corporation Information 12.13.2 Shuanglin Bio-pharmacy Description and Business Overview 12.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shuanglin Bio-pharmacy Products Offered 12.13.5 Shuanglin Bio-pharmacy Recent Development 12.14 Sichuan Yuanda Shuyang 12.14.1 Sichuan Yuanda Shuyang Corporation Information 12.14.2 Sichuan Yuanda Shuyang Description and Business Overview 12.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Sichuan Yuanda Shuyang Products Offered 12.14.5 Sichuan Yuanda Shuyang Recent Development 12.15 Shanghai Institute of Biological 12.15.1 Shanghai Institute of Biological Corporation Information 12.15.2 Shanghai Institute of Biological Description and Business Overview 12.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Shanghai Institute of Biological Products Offered 12.15.5 Shanghai Institute of Biological Recent Development 12.16 Hualan 12.16.1 Hualan Corporation Information 12.16.2 Hualan Description and Business Overview 12.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Hualan Products Offered 12.16.5 Hualan Recent Development 12.17 Shanghai RAAS Blood Products 12.17.1 Shanghai RAAS Blood Products Corporation Information 12.17.2 Shanghai RAAS Blood Products Description and Business Overview 12.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Shanghai RAAS Blood Products Products Offered 12.17.5 Shanghai RAAS Blood Products Recent Development 12.18 China Grand Enterprises 12.18.1 China Grand Enterprises Corporation Information 12.18.2 China Grand Enterprises Description and Business Overview 12.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.18.4 China Grand Enterprises Products Offered 12.18.5 China Grand Enterprises Recent Development 12.19 Nanyue Biopharmaceutical 12.19.1 Nanyue Biopharmaceutical Corporation Information 12.19.2 Nanyue Biopharmaceutical Description and Business Overview 12.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Nanyue Biopharmaceutical Products Offered 12.19.5 Nanyue Biopharmaceutical Recent Development 12.20 Boya Biopharmaceutical Group 12.20.1 Boya Biopharmaceutical Group Corporation Information 12.20.2 Boya Biopharmaceutical Group Description and Business Overview 12.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Boya Biopharmaceutical Group Products Offered 12.20.5 Boya Biopharmaceutical Group Recent Development 12.21 Tonglu Biopharmaceutical 12.21.1 Tonglu Biopharmaceutical Corporation Information 12.21.2 Tonglu Biopharmaceutical Description and Business Overview 12.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Tonglu Biopharmaceutical Products Offered 12.21.5 Tonglu Biopharmaceutical Recent Development 12.22 Shandong Taibang Biopharmaceutical 12.22.1 Shandong Taibang Biopharmaceutical Corporation Information 12.22.2 Shandong Taibang Biopharmaceutical Description and Business Overview 12.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Shandong Taibang Biopharmaceutical Products Offered 12.22.5 Shandong Taibang Biopharmaceutical Recent Development 12.23 Guangdong Shuanglin Biopharmaceutical 12.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information 12.23.2 Guangdong Shuanglin Biopharmaceutical Description and Business Overview 12.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Guangdong Shuanglin Biopharmaceutical Products Offered 12.23.5 Guangdong Shuanglin Biopharmaceutical Recent Development 12.24 Chengdu Rongsheng Pharmaceutical 12.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information 12.24.2 Chengdu Rongsheng Pharmaceutical Description and Business Overview 12.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Chengdu Rongsheng Pharmaceutical Products Offered 12.24.5 Chengdu Rongsheng Pharmaceutical Recent Development 12.25 Shenzhen Weiguang Biopharmaceutical 12.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information 12.25.2 Shenzhen Weiguang Biopharmaceutical Description and Business Overview 12.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Shenzhen Weiguang Biopharmaceutical Products Offered 12.25.5 Shenzhen Weiguang Biopharmaceutical Recent Development 12.26 Green Cross (China) Biological Products 12.26.1 Green Cross (China) Biological Products Corporation Information 12.26.2 Green Cross (China) Biological Products Description and Business Overview 12.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.26.4 Green Cross (China) Biological Products Products Offered 12.26.5 Green Cross (China) Biological Products Recent Development 12.27 Sinopharm 12.27.1 Sinopharm Corporation Information 12.27.2 Sinopharm Description and Business Overview 12.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.27.4 Sinopharm Products Offered 12.27.5 Sinopharm Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Hepatitis B Human Immunoglobulin Industry Trends 13.2 Hepatitis B Human Immunoglobulin Market Drivers 13.3 Hepatitis B Human Immunoglobulin Market Challenges 13.4 Hepatitis B Human Immunoglobulin Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hepatitis B Human Immunoglobulin Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryMarket Analysis and Insights: Global and China Hepatitis B Human Immunoglobulin Market Table of Contents1 Study Coverage1.1 Hepatitis B Human Immunoglobulin Product Introduction 1.2 Market by Type 1.2.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Type 1.2.2 100IU 1.2.3 200IU 1.2.4 400IU 1.3 Market by Application 1.3.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Application 1.3.2 Measles Prevention 1.3.3 Prevention of Hepatitis B Virus Infection 1.3.4 Hepatitis A Virus Infection 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Hepatitis B Human Immunoglobulin Market Size, Estimates and Forecasts 2.1.1 Global Hepatitis B Human Immunoglobulin Revenue 2016-2027 2.1.2 Global Hepatitis B Human Immunoglobulin Sales 2016-2027 2.2 Global Hepatitis B Human Immunoglobulin, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Hepatitis B Human Immunoglobulin Historical Market Size by Region (2016-2021) 2.3.1 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Region (2022-2027) 2.4.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Region (2022-2027) 3 Global Hepatitis B Human Immunoglobulin Competitor Landscape by Players 3.1 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Sales 3.1.1 Global Hepatitis B Human Immunoglobulin Sales by Manufacturer (2016-2021) 3.1.2 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Revenue 3.2.1 Key Hepatitis B Human Immunoglobulin Manufacturers Covered: Ranking by Revenue 3.2.2 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers (2016-2021) 3.2.3 Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Hepatitis B Human Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Hepatitis B Human Immunoglobulin Revenue in 2020 3.2.6 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Hepatitis B Human Immunoglobulin Price by Manufacturers 3.4 Global Hepatitis B Human Immunoglobulin Manufacturing Base Distribution, Product Types 3.4.1 Hepatitis B Human Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hepatitis B Human Immunoglobulin Product Type 3.4.3 Date of International Manufacturers Enter into Hepatitis B Human Immunoglobulin Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Hepatitis B Human Immunoglobulin Market Size by Type (2016-2021) 4.1.1 Global Hepatitis B Human Immunoglobulin Sales by Type (2016-2021) 4.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2016-2021) 4.1.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Hepatitis B Human Immunoglobulin Market Size Forecast by Type (2022-2027) 4.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027) 4.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027) 4.2.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Hepatitis B Human Immunoglobulin Market Size by Application (2016-2021) 5.1.1 Global Hepatitis B Human Immunoglobulin Sales by Application (2016-2021) 5.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2016-2021) 5.1.3 Hepatitis B Human Immunoglobulin Price by Application (2016-2021) 5.2 Hepatitis B Human Immunoglobulin Market Size Forecast by Application (2022-2027) 5.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027) 5.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027) 5.2.3 Global Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 6.1.1 China Hepatitis B Human Immunoglobulin Sales YoY Growth 2016-2027 6.1.2 China Hepatitis B Human Immunoglobulin Revenue YoY Growth 2016-2027 6.1.3 China Hepatitis B Human Immunoglobulin Market Share in Global Market 2016-2027 6.2 China Hepatitis B Human Immunoglobulin Market Size by Players (International and Local Players) 6.2.1 China Top Hepatitis B Human Immunoglobulin Players by Sales (2016-2021) 6.2.2 China Top Hepatitis B Human Immunoglobulin Players by Revenue (2016-2021) 6.3 China Hepatitis B Human Immunoglobulin Historic Market Review by Type (2016-2021) 6.3.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2021) 6.3.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2016-2021) 6.3.3 China Hepatitis B Human Immunoglobulin Price by Type (2016-2021) 6.4 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027) 6.4.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027) 6.4.3 China Hepatitis B Human Immunoglobulin Price Forecast by Type (2022-2027) 6.5 China Hepatitis B Human Immunoglobulin Historic Market Review by Application (2016-2021) 6.5.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2021) 6.5.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2016-2021) 6.5.3 China Hepatitis B Human Immunoglobulin Price by Application (2016-2021) 6.6 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027) 6.6.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027) 6.6.3 China Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027) 7 North America 7.1 North America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 7.2 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 7.2.1 North America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 7.2.2 North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 8.2 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Region 8.2.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2016-2021) 8.2.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 9.2 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 9.2.1 Europe Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 9.2.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 10.2 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 10.2.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 10.2.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country 11.2.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) 11.2.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Biotest 12.1.1 Biotest Corporation Information 12.1.2 Biotest Description and Business Overview 12.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Biotest Hepatitis B Human Immunoglobulin Products Offered 12.1.5 Biotest Recent Development 12.2 ADMA Biologics 12.2.1 ADMA Biologics Corporation Information 12.2.2 ADMA Biologics Description and Business Overview 12.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Products Offered 12.2.5 ADMA Biologics Recent Development 12.3 Sanquin Blood 12.3.1 Sanquin Blood Corporation Information 12.3.2 Sanquin Blood Description and Business Overview 12.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Products Offered 12.3.5 Sanquin Blood Recent Development 12.4 Bio Products Laboratory 12.4.1 Bio Products Laboratory Corporation Information 12.4.2 Bio Products Laboratory Description and Business Overview 12.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Products Offered 12.4.5 Bio Products Laboratory Recent Development 12.5 Baxter 12.5.1 Baxter Corporation Information 12.5.2 Baxter Description and Business Overview 12.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Baxter Hepatitis B Human Immunoglobulin Products Offered 12.5.5 Baxter Recent Development 12.6 CSL 12.6.1 CSL Corporation Information 12.6.2 CSL Description and Business Overview 12.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.6.4 CSL Hepatitis B Human Immunoglobulin Products Offered 12.6.5 CSL Recent Development 12.7 Bayer 12.7.1 Bayer Corporation Information 12.7.2 Bayer Description and Business Overview 12.7.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Bayer Hepatitis B Human Immunoglobulin Products Offered 12.7.5 Bayer Recent Development 12.8 Grifols 12.8.1 Grifols Corporation Information 12.8.2 Grifols Description and Business Overview 12.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Grifols Hepatitis B Human Immunoglobulin Products Offered 12.8.5 Grifols Recent Development 12.9 Octapharma 12.9.1 Octapharma Corporation Information 12.9.2 Octapharma Description and Business Overview 12.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Octapharma Hepatitis B Human Immunoglobulin Products Offered 12.9.5 Octapharma Recent Development 12.10 Hualan Biological 12.10.1 Hualan Biological Corporation Information 12.10.2 Hualan Biological Description and Business Overview 12.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Products Offered 12.10.5 Hualan Biological Recent Development 12.11 Biotest 12.11.1 Biotest Corporation Information 12.11.2 Biotest Description and Business Overview 12.11.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Biotest Hepatitis B Human Immunoglobulin Products Offered 12.11.5 Biotest Recent Development 12.12 Tiantan Biologic 12.12.1 Tiantan Biologic Corporation Information 12.12.2 Tiantan Biologic Description and Business Overview 12.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Tiantan Biologic Products Offered 12.12.5 Tiantan Biologic Recent Development 12.13 Shuanglin Bio-pharmacy 12.13.1 Shuanglin Bio-pharmacy Corporation Information 12.13.2 Shuanglin Bio-pharmacy Description and Business Overview 12.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Shuanglin Bio-pharmacy Products Offered 12.13.5 Shuanglin Bio-pharmacy Recent Development 12.14 Sichuan Yuanda Shuyang 12.14.1 Sichuan Yuanda Shuyang Corporation Information 12.14.2 Sichuan Yuanda Shuyang Description and Business Overview 12.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Sichuan Yuanda Shuyang Products Offered 12.14.5 Sichuan Yuanda Shuyang Recent Development 12.15 Shanghai Institute of Biological 12.15.1 Shanghai Institute of Biological Corporation Information 12.15.2 Shanghai Institute of Biological Description and Business Overview 12.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Shanghai Institute of Biological Products Offered 12.15.5 Shanghai Institute of Biological Recent Development 12.16 Hualan 12.16.1 Hualan Corporation Information 12.16.2 Hualan Description and Business Overview 12.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Hualan Products Offered 12.16.5 Hualan Recent Development 12.17 Shanghai RAAS Blood Products 12.17.1 Shanghai RAAS Blood Products Corporation Information 12.17.2 Shanghai RAAS Blood Products Description and Business Overview 12.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Shanghai RAAS Blood Products Products Offered 12.17.5 Shanghai RAAS Blood Products Recent Development 12.18 China Grand Enterprises 12.18.1 China Grand Enterprises Corporation Information 12.18.2 China Grand Enterprises Description and Business Overview 12.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.18.4 China Grand Enterprises Products Offered 12.18.5 China Grand Enterprises Recent Development 12.19 Nanyue Biopharmaceutical 12.19.1 Nanyue Biopharmaceutical Corporation Information 12.19.2 Nanyue Biopharmaceutical Description and Business Overview 12.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Nanyue Biopharmaceutical Products Offered 12.19.5 Nanyue Biopharmaceutical Recent Development 12.20 Boya Biopharmaceutical Group 12.20.1 Boya Biopharmaceutical Group Corporation Information 12.20.2 Boya Biopharmaceutical Group Description and Business Overview 12.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Boya Biopharmaceutical Group Products Offered 12.20.5 Boya Biopharmaceutical Group Recent Development 12.21 Tonglu Biopharmaceutical 12.21.1 Tonglu Biopharmaceutical Corporation Information 12.21.2 Tonglu Biopharmaceutical Description and Business Overview 12.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Tonglu Biopharmaceutical Products Offered 12.21.5 Tonglu Biopharmaceutical Recent Development 12.22 Shandong Taibang Biopharmaceutical 12.22.1 Shandong Taibang Biopharmaceutical Corporation Information 12.22.2 Shandong Taibang Biopharmaceutical Description and Business Overview 12.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Shandong Taibang Biopharmaceutical Products Offered 12.22.5 Shandong Taibang Biopharmaceutical Recent Development 12.23 Guangdong Shuanglin Biopharmaceutical 12.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information 12.23.2 Guangdong Shuanglin Biopharmaceutical Description and Business Overview 12.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Guangdong Shuanglin Biopharmaceutical Products Offered 12.23.5 Guangdong Shuanglin Biopharmaceutical Recent Development 12.24 Chengdu Rongsheng Pharmaceutical 12.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information 12.24.2 Chengdu Rongsheng Pharmaceutical Description and Business Overview 12.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Chengdu Rongsheng Pharmaceutical Products Offered 12.24.5 Chengdu Rongsheng Pharmaceutical Recent Development 12.25 Shenzhen Weiguang Biopharmaceutical 12.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information 12.25.2 Shenzhen Weiguang Biopharmaceutical Description and Business Overview 12.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Shenzhen Weiguang Biopharmaceutical Products Offered 12.25.5 Shenzhen Weiguang Biopharmaceutical Recent Development 12.26 Green Cross (China) Biological Products 12.26.1 Green Cross (China) Biological Products Corporation Information 12.26.2 Green Cross (China) Biological Products Description and Business Overview 12.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.26.4 Green Cross (China) Biological Products Products Offered 12.26.5 Green Cross (China) Biological Products Recent Development 12.27 Sinopharm 12.27.1 Sinopharm Corporation Information 12.27.2 Sinopharm Description and Business Overview 12.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021) 12.27.4 Sinopharm Products Offered 12.27.5 Sinopharm Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Hepatitis B Human Immunoglobulin Industry Trends 13.2 Hepatitis B Human Immunoglobulin Market Drivers 13.3 Hepatitis B Human Immunoglobulin Market Challenges 13.4 Hepatitis B Human Immunoglobulin Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hepatitis B Human Immunoglobulin Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（hepatitis）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
